SORL1 and neoplasm: We anticipate that SorLA ab triggers its anti‐tumor effects upon binding to the cell‐surface pool of SorLA prior to the retrograde trafficking pathway since it is reported that low pH, corresponding to acidic milieu of endocytic vesicles, decreases CRD binding to cargo proteins [35].